Ra Medical Systems, Inc. (NYSE:RMED) is among the top gainers of the stock market today, skyrocketing 9.21% or (0.42 points) to $4.98 from its previous close of $4.56. Does this growth mean it the best stock to buy right now? The shares seem to have an active trading volume day with a reported 124504 contracts so far this session. RMED shares had a relatively better volume day versus average trading capacity of 121.46 thousand shares, but with a 6.87 million float and a 12.59% run over a week, it’s definitely worth keeping an eye on. The one year price forecast for RMED stock indicates that the average analyst price target is $11.75 per share. This means the stock has a potential increase of 135.94% from where the RMED share price has been trading recently which is between $4.105 and $4.5731. There are some brokerage firms that offer lower targets than the average, with one of them, even setting their price target at $9.
The most recent news story about the stock that appeared in Yahoo Finance‘s news section was titled “Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ra Medical Systems, Inc. (RMED)” and dated May 17, 2019.
Looking at the current readings for Ra Medical Systems, Inc., the two-week RSI stands at 63.7. This figure suggests that RMED stock, for now, is neutral, meaning that the shares are stable in terms of price movement. The stochastic readings, on the other hand, based on the current RMED readings is similarly very revealing as it has a stochastic reading of 68.87% at this stage. This figure means that RMED share price today is being neutral.
Technical chart claims that Ra Medical Systems, Inc. (RMED) would settle between $4.72/share to $4.88/share level. However, if the stock price goes below the $4.25 mark, then the market for Ra Medical Systems, Inc. becomes much weaker. If that happens, the stock price might even plunge as low as $3.94 for its downside target. The stock is currently in the green zone of MACD, with the indicator reading 0.32. Traders are always alerted for the move of a stock above or below the zero line due to the fact that the reading is an indicator of the position of the short-term average relative to the long-term average. If the MACD is above the zero line, then the short-term average relative is above that of the long-term average, thus implying an upward momentum. Vice versa is the case if the MACD is below the zero line.
Analysts at Maxim Group, assumed coverage of RMED assigning Buy rating, according to their opinion released on November 02.
RMED equity has an average rating of 2, with the figure leaning towards a bullish end. 3 analysts who tracked the company were contacted by Reuters. Amongst them, 0 rated the stock as a hold while the remaining 3 were split even though not equally. Some analysts rate the stock as a buy or a strong buy while no rated it as a sell. 3 analysts rated Ra Medical Systems, Inc. (NYSE:RMED) as a buy or a strong buy while not a single analyst advised that investors should desist from purchasing the stock or sell them if they already own the company’s stock.
Moving on, RMED stock price is currently trading at 0X forward 12-month Consensus EPS estimates, and its P/S ratio is 9.42 while for the average stock in the same group, the multiple is 19.67.